PTEN通过PU.1-依赖的染色质可访问性来调节造血系的可塑性
Zihan Xu1, Libing He2, Yilin Wu2
1The MOE Key Laboratory of Cell Proliferation and Differentiation, Center for Bioinformatics, School of Life Sciences, Peking University, Beijing, China; Center for Statistical Science, Peking University, Beijing, China.
Cell reports
|August 10, 2023
概括
在造血干细胞 (HSC) 中的PTEN损失通过改变细胞发育驱动白血病. 一个关键的转录因子PU.1,可以重新编程这些细胞,提供新的治疗点.
科学领域:
- 血液形成 血液形成 血液形成
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 造血干细胞 (HSC) 中的PTEN损失与改变的血统潜力和T细胞急性淋巴细胞白血病 (T-ALL) 有关.
- 了解PTEN调节血统承诺的精确机制对于白血病研究至关重要.
研究的目的:
- 调查PTEN损失影响血液生成系选择的分子机制.
- 为了确定关键的发育阶段和转录因子涉及PTEN介导的血统可塑性.
主要方法:
- 从小鼠前白血病HSC获得的ATAC-seq和单细胞RNA-seq数据的综合分析.
- 在体外培养实验中,使用Pten-null预先B细胞进行培养.
- 功能性研究涉及操纵PU.1水平.
主要成果:
- 在前B细胞阶段,PTEN损失改变了在临界转录因子结合部位的染色质可访问性.
- 这种表观遗传重编程导致骨髓和T细胞潜力增加,B细胞潜力降低.
- PU.1 作为PTEN的关键下游效应因子,能够在Pten-null细胞中重新编程染色质可访问性和谱系潜力.
结论:
- 前B细胞阶段是PTEN调节的造血系决定的关键窗口.
- PU.1在调节前亲B祖先的表观遗传景观和血统可塑性方面发挥着关键作用,这表明它在T-ALL发育中的重要性.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Pleiotropy
40.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.6K


